It is an oldest medicine used to treat various neurodegenrative diseases [65, 66]
While patient stories are compelling (such as recovery from stubborn tendonitis in weeks) its important to remember that BPC-157 is still under study, and to always consult a qualified clinician before use
individuals with obesity are 35 times more likely to develop OA [75], and most OA patients undergoing total joint replacement surgery for end-stage OA have obesity or are overweight [76]
Max Cohen, the director of the medical weight loss center at Care New England
These ads falsely claim compounded medicines are identical to FDA-approved brands, even though the FDA has not evaluated the products or their active ingredientswhich most American consumers dont know
[2] After the promising results from the 12-week trial, a more extended 24-week trial was conducted with a larger group of 536 subjects